Shareholding disclosure
Kuros Biosciences AG
Collectively declared rate
11.76%
Threshold
Crossed upwards
Timeline
Published
05.02.2015
Transaction
30.01.2015
Voting rights breakdown
Declared beneficial owners · 3
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
Notification ID
TBF2400020
Beneficial owner
Corey Goodman
Declared address
Corey Goodman, Marshall
Expiry of the conversion rights under the convertible loan notes. Warrants and options are directly held by venBio Global Strategic Fund L.P. c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, Georg Town,Grand Cayman KYI-9005, Cayman Islands, which is controlled by venBio Global Strategic GP L.P., c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman KYI-9005, Cayman Islands, as general partner. venBio Global Strategic GP L.P, in turn, is controlled by venBio Global Strategic GP Ltd., c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman KYI-9005, Cayman Islands, as general partner. venBio Global Strategic GP Ltd. is jointly controlled by Corey Goodman, Marshall, USA, Paul Brooke, New York, USA, and Robert Adelman, Hillsborough, USA. Paul Brooke also hold certain employee options on shares in the Company directly.
insider24.ch
Never miss a market signal again
Need more? Discover the Pro plan